Author: PharmAla Biotech

Posted Date:

March 3, 2026

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders

PharmAla Biotech

March 3, 2026
PharmAla To Supply Amsterdam UMC with LaNeo™ MDMA, Including Development of New Single-Capsule Stability Data

PharmAla Biotech

February 23, 2026
PharmAla Announces Changes to Board of Directors

PharmAla Biotech

February 16, 2026